Mourad Errasfa

Prof. Mourad Errasfa

Faculty of medicine, pharmacy and dentistry, University of Sidi Mohamed Ben Abdellah, Fès, Fès-Meknès, Morocco

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2017 in Current Rheumatology Reviews
Verified
Journal Article
Closed access
PDF file
JEJamila Essouiri
Jamila Essouiri
THTaoufik Harzy
Taoufik Harzy
NBNadia Benaicha
Nadia Benaicha
MEMourad Errasfa
Mourad Errasfa
FAFatima Ezzahra Abourazzak
Fatima Ezzahra Abourazzak
Background: Knee osteoarthritis (KOA) is a common chronic degenerative disorder. It causes joint pain, walking difficulties and a decline in general physical function. Many pain drugs and treatment modalities can be prescribed for KOA. Among traditional medicines in Morocco, Argan oil has been used in the treatment of knee osteoarthritis to reduce pain and improve physical activity, though there have been no medical-based evidence for such treatment. Argan oil is known to have anti-oxidant and lipid modulatory properties due to its content of many substances, such as tocopherols, phytosterols, saturated and unsaturated fatty acids. Objectives: This study was undertaken in order to investigate the effect of daily consumption of culinary argan oil on KOA symptoms. Patients and Methods: We conducted a randomized controlled clinical trial on patients with KOA according to the American College of Rheumatology (ACR) criteria. Patients were divided into 2 groups: argan oil group who received argan oil to be consumed every morning (30 ml per day) for 8 weeks and control group with no treatment. Clinical assessment before and after 8 weeks study was performed by several tests such as the Visual Analogue Scale (VAS) for pain, walking perimeter, the Western Ontario and McMaster Universities osteoarthritis index (WOMAC), and the Lequesne index. Results: The study included 100 patients. 51 patients were randomly assigned to argan oilgroup while 49 patients were randomly assigned to control group with no treatment. Mean age of our patients was 58.24 ± 7.2 years, with a majority of women (93%). Following 8 weeks of argan oil consumption, argan oil group had a very significant decrease of VAS for pain (p< 0.0001), with a significant decrease in WOMAC pain index (p < 0.0001), and improvement of WOMAC function index (p < 0.0001). Lequesne index (p < 0.0001) as well as walking distance (p =0,002) significantly improved. When data of argan oil group were compared to those of control group, we found statistically significant differences in all the above measured parameters: VAS of pain (P=0,02), WOMAC pain (p<0,0001), WOMAC function (p<0,0001), walking distance (p=0,001) and lequesne index (p<0,0001). Conclusion: Patient's consumption of argan oil seems to be safe and efficacious in improving clinical symptoms of KOA.

11 September 1991 in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Verified
Journal Article
Closed access
MEMourad Errasfa
Mourad Errasfa

8 February 2021 in Current Nutrition & Food Science
Verified
Journal Article
Closed access
PDF file
MEMourad Errasfa
Mourad Errasfa
Background: Covid-19 pandemic is causing a very high death toll around the world and a severe fall in the global economy. Many clinical trials are currently underway to check the effectiveness of some known drugs. The physiopathology associated with the virus infection is currently better understood and good prophylactic drug therapies are implemented, such as antibiotics and blood thinners, though, no specific drugs against SARS-Cov-2 were developed yet.Objective: In the present research work, it is aimed to carry out a bibliographic investigation on some active molecular species that could be used against Covid-19, based on their chemical properties to bind to glycoproteins. In the case of SARS-Cov-2, the targeted glycoprotein is the surface virus spike S glycoprotein, that the virus uses to attach to and invade human cells. It is of high pharmacological value to investigate possible active natural substances endowed with a property to bind glycoproteins. In this line of research, oligosaccharides and lectins are two molecular species that have glycoprotein binding properties.Methods: A bibliographic research was carried out on oligosaccharides and lectins in various sources of scientific publications. Relevant chemical and pharmacological properties of oligosaccharides and lectins were searched and their main natural sources were identified.Results: In the present paper, I summarize some scientific evidence to support the therapeutic potential of camel milk as a source of oligosaccharides and its possible use as a functional diet in parallel to drug therapies of Covid-19. On the other hand, sugar and glycoprotein binding properties of some lectins of plant and seaweed origin are reported, and their pharmaceutical use is underlined.Conclusion: In the present study, scientific evidence was documented that encouraged further clinical investigations on camel milk oligosaccharides and lectins of plant and seaweed origin in the management of Covid-19 physiopathology.

20 April 2018 in Current Rheumatology Reviews
Verified
Journal Article
Closed access
JEJamila Essouiri
Jamila Essouiri
FAFatima Ezzahra Abourazzak
Fatima Ezzahra Abourazzak
FLFaiza Lazrak
Faiza Lazrak
ANAdil Najdi
Adil Najdi
NBNadia Benaicha
Nadia Benaicha
MEMourad Errasfa
Mourad Errasfa
Five medical conditions characterizes metabolic syndrome: abdominal obesity, elevated blood pressure, elevated fasting plasma glucose, high serum triglycerides, and low high-density lipoproteins cholesterol. When a patient has three of the five above parameters, he is called to have metabolic syndrome, and these conditions represents a key element in cardiovascular diseases. On the other hand, knee osteoarthritis is a degenerative disease which was shown to be affected by some of the parameters of metabolic syndrome. Edible Argane oil is used in Moroccan folk medicine against several health conditions, such as knee osteoarthritis, though, evidence-based medical data about the above health benefit from Argane oil treatment are lacking. In the present clinical controlled study, we have found that consumption of Argane oil by 38 patients who have knee osteoarthritis and metabolic syndrome can improve several of their metabolic syndrome parameters and decrease their blood lipid atherogenic ratios. The present clinical study, to the best of our knowledge, is the first one to show that Argane oil consumption could be a therapeutic preventive tool against key cardiovascular risk factors of metabolic syndrome in knee osteoarthritis patients.

2 March 2021 in The Open Toxicology Journal
Verified
Journal Article
Open access
PDF file
MEMourad Errasfa
Mourad Errasfa
Blood Hemostasis Dysfunction and Inflammation in COVID-19 Patients: Viral and Host Active Molecules as Therapeutic Targets